๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this research study is to evaluate a new drug pembrolizumab ...
Status
Unknown
Location
Stanford Cancer Institute
Start Date
2017-11-09
Trial ID
NCT03226249
This study aims to investigate the value of 18F-FDG\&68Ga-FAPI PET/CT i...
Status
Recruiting
Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Start Date
2024-06-15
Trial ID
NCT06597526
The purpose of this study is to assess whether patients who are likely to f...
Status
Unknown
Location
BC Cancer Agency
Start Date
2006-08
Trial ID
NCT00324467
Etiology and cognitive prognosis in late onset epilepsy differ from young a...
Status
Unknown
Location
CHRU Nancy
Start Date
2023-05-02
Trial ID
NCT05831371
Treatments Being Tested
Influence of diabetic neuropathy on cold induced brown adipose tissue in ty...
Status
Unknown
Location
Geneva University Hospital
Start Date
2018-10-15
Trial ID
NCT03695731
Treatments Being Tested
To evaluate the potential usefulness of 68Ga-DOTA-FAPI-04 positron emission...
Status
Recruiting
Location
First affiliated hospital of xiamen university
Start Date
2019-10-20
Trial ID
NCT04416165
Treatments Being Tested
In terms of the diagnostic technology of brain neurodegenerative diseases, ...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2022-11-01
Trial ID
NCT06344845
Treatments Being Tested
The purpose of this study is to find out whether 68Ga-PSMA-11 PET/CT is eff...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Start Date
2024-01-05
Trial ID
NCT06209567
Treatments Being Tested
The aim of the study is to identify and characterize lesions in the abdomin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08
Trial ID
NCT07127627
Treatments Being Tested
This is a prospective, multicenter, self-controlled phase 3 clinical trial ...
Status
Completed
Location
Peking University Cancer Hospital & Institute
Start Date
2019-10-12
Trial ID
NCT04233476
Treatments Being Tested